{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:51:40Z","timestamp":1781949100874,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SHOWA Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12282-026-01863-2","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:52:54Z","timestamp":1778647974000},"page":"887-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Miharu","family":"Kano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7754-1548","authenticated-orcid":false,"given":"Kanae","family":"Taruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Haruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"1863_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1863_CR2","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine. 2024;103:e36905.","journal-title":"Medicine"},{"key":"1863_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, et al. Breast cancer risk genes-association analysis in more than 113,000 women. N Engl J Med. 2021;384:428\u201339.","journal-title":"N Engl J Med"},{"key":"1863_CR4","doi-asserted-by":"publisher","first-page":"1248492","DOI":"10.3389\/fgene.2023.1248492","volume":"14","author":"M Zanti","year":"2023","unstructured":"Zanti M, Loizidou MA, O\u2019Mahony DG, Dorling L, Dennis J, Devilee P, et al. Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls. Front Genet. 2023;14:1248492.","journal-title":"Front Genet"},{"key":"1863_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37:453\u201360.","journal-title":"J Clin Oncol"},{"key":"1863_CR6","doi-asserted-by":"publisher","first-page":"e2431427","DOI":"10.1001\/jamanetworkopen.2024.31427","volume":"7","author":"Z Rezoug","year":"2024","unstructured":"Rezoug Z, Totten SP, Szlachtycz D, Atayan A, Mohler K, Albert S, et al. Universal genetic testing for newly diagnosed invasive breast cancer. JAMA Netw Open. 2024;7:e2431427.","journal-title":"JAMA Netw Open"},{"key":"1863_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1200\/JCO.19.02190","volume":"38","author":"S Yadav","year":"2020","unstructured":"Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, et al. Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol. 2020;38:1409\u201318.","journal-title":"J Clin Oncol"},{"key":"1863_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721\u201330.","journal-title":"Cancer"},{"key":"1863_CR9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3919\/jjsa.83.1381","volume":"83","author":"R Narui","year":"2022","unstructured":"Narui R, Taruno K, Akashi S, Nakamura S. A clinical study of cases in which BRCA1\/2 genetic tests were performed after insurance coverage as additional indication and future problems. J Jpn Surg Assoc. 2022;83:1381\u201392.","journal-title":"J Jpn Surg Assoc"},{"key":"1863_CR10","doi-asserted-by":"publisher","first-page":"7580","DOI":"10.1002\/cam4.5515","volume":"12","author":"KA Metcalfe","year":"2023","unstructured":"Metcalfe KA, Narod SA, Eisen A, Poll A, Zamani N, McCready D, et al. Genetic testing women with newly diagnosed breast cancer: what criteria are the most predictive of a positive test? Cancer Med. 2023;12:7580\u20137.","journal-title":"Cancer Med"},{"key":"1863_CR11","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1200\/JCO.20.03661","volume":"39","author":"ZK Stadler","year":"2021","unstructured":"Stadler ZK, Maio A, Chakravarty D, Kemel Y, Sheehan M, Salo-Mullen E, et al. Therapeutic implications of germline testing in patients with advanced cancers. J Clin Oncol. 2021;39:2698\u2013709.","journal-title":"J Clin Oncol"},{"key":"1863_CR12","doi-asserted-by":"publisher","first-page":"1420190","DOI":"10.3389\/fgene.2024.1420190","volume":"15","author":"M Zalis","year":"2024","unstructured":"Zalis M, Viana Veloso GG, Aguiar PN Jr, Gimenes N, Reis MX, Matsas S, et al. Next-generation sequencing impact on cancer care: applications, challenges, and future directions. Front Genet. 2024;15:1420190.","journal-title":"Front Genet"},{"key":"1863_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jval.2020.09.016","volume":"24","author":"A Koldehoff","year":"2021","unstructured":"Koldehoff A, Danner M, Civello D, Rhiem K, Stock S, M\u00fcller D. Cost-effectiveness of targeted genetic testing for breast and ovarian cancer: a systematic review. Value Health. 2021;24:303\u201312.","journal-title":"Value Health"},{"key":"1863_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","volume":"388","author":"Y Usui","year":"2023","unstructured":"Usui Y, Taniyama Y, Endo M, Koyanagi YN, Kasugai Y, Oze I, et al. Helicobacter pylori, homologous-recombination genes, and gastric cancer. N Engl J Med. 2023;388:1181\u201390.","journal-title":"N Engl J Med"},{"key":"1863_CR15","first-page":"5027","volume":"25","author":"Y Momozawa","year":"2016","unstructured":"Momozawa Y, Akiyama M, Kamatani Y, Arakawa S, Yasuda M, Yoshida S, et al. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Hum Mol Genet. 2016;25:5027\u201334.","journal-title":"Hum Mol Genet"},{"key":"1863_CR16","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018;9:4083.","journal-title":"Nat Commun"},{"key":"1863_CR17","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whitworth PW, et al. Clinical evaluation of a multiple gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014;32:2001\u20139.","journal-title":"J Clin Oncol"},{"key":"1863_CR18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190\u20136.","journal-title":"JAMA Oncol"},{"key":"1863_CR19","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2.2024."},{"key":"1863_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/GCO.0000000000000764","volume":"34","author":"EL Silver","year":"2022","unstructured":"Silver EL, Niell Swiller M. Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel? Curr Opin Obstet Gynecol. 2022;34:36\u201340.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1863_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.6004\/jnccn.2017.0107","volume":"15","author":"C Cropper","year":"2017","unstructured":"Cropper C, Woodson A, Arun B, Barcenas C, Litton J, Noblin S, et al. Evaluating the NCCN clinical criteria for recommending BRCA1 and BRCA2 genetic testing in patients with breast cancer. J Natl Compr Canc Netw. 2017;15:797\u2013803.","journal-title":"J Natl Compr Canc Netw"},{"key":"1863_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5694\/mja2.51906","volume":"218","author":"DL De Silva","year":"2023","unstructured":"De Silva DL, Stafford L, Skandarajah AR, Sinclair M, Devereux L, Hogg K, et al. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. Med J Aust. 2023;218:368\u201373.","journal-title":"Med J Aust"},{"key":"1863_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pathol.2017.03.002","volume":"49","author":"MG Keeney","year":"2017","unstructured":"Keeney MG, Couch FJ, Visscher DW, Lindor NM. Non-BRCA familial breast cancer: review of reported pathology and molecular findings. Pathology. 2017;49:363\u201370.","journal-title":"Pathology"},{"key":"1863_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41523-020-0163-1","volume":"6","author":"T Kaneyasu","year":"2020","unstructured":"Kaneyasu T, Mori S, Yamauchi H, Ohsumi S, Ohno S, Aoki D, et al. Prevalence of disease-causing genes in Japanese patients with BRCA1\/2-wildtype hereditary breast and ovarian cancer syndrome. NPJ Breast Cancer. 2020;6:25.","journal-title":"NPJ Breast Cancer"},{"key":"1863_CR25","doi-asserted-by":"publisher","first-page":"e216744","DOI":"10.1001\/jamaoncol.2021.6744","volume":"8","author":"N Mavaddat","year":"2022","unstructured":"Breast Cancer Association Consortium, Mavaddat N, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, et al. Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes. JAMA Oncol. 2022;8:e216744.","journal-title":"JAMA Oncol"},{"key":"1863_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.breast.2022.06.003","volume":"65","author":"R Graffeo","year":"2022","unstructured":"Graffeo R, Rana HQ, Conforti F, Bonanni B, Cardoso MJ, Paluch-Shimon S, et al. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. Breast. 2022;65:32\u201340.","journal-title":"Breast"},{"key":"1863_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","volume":"110","author":"H Shimelis","year":"2018","unstructured":"Shimelis H, LaDuca H, Hu C, Hart SN, Na J, Thomas A, et al. Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing. J Natl Cancer Inst. 2018;110:855\u201362.","journal-title":"J Natl Cancer Inst"},{"key":"1863_CR28","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/diagnostics14171875","volume":"14","author":"VB Varzaru","year":"2024","unstructured":"Varzaru VB, Vlad T, Popescu R, Vlad CS, Moatar AE, Cobec IM. Triple-negative breast cancer: molecular particularities still a challenge. Diagnostics. 2024;14:1875.","journal-title":"Diagnostics"},{"key":"1863_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13045-019-0725-6","volume":"12","author":"ZS Lima","year":"2019","unstructured":"Lima ZS, Ghadamzadeh M, Arashloo FT, Amjad G, Ebadi MR, Younesi L. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. J Hematol Oncol. 2019;12:38.","journal-title":"J Hematol Oncol"},{"key":"1863_CR30","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12282-025-01704-8","volume":"32","author":"M Takahashi","year":"2025","unstructured":"Takahashi M, Minoura Y, Den H, Nomizu T, Ishida T, Kumamaru H, et al. Analysis of the conditions for applying BRCA genetic testing to women with breast cancer using the Japanese HBOC consortium and the Japanese organization of hereditary breast and ovarian cancer (JOHBOC) registry project database. Breast Cancer. 2025;32:792\u2013802.","journal-title":"Breast Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01863-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:22:26Z","timestamp":1781947346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01863-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01863-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Showa University Research Ethics Review Board [approval No, 22-066-A]. Informed consent was obtained from all participants involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}